Remove FDA Remove Health Services Administration Remove Public Health
article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment GapsĀ 

Bill of Health

health care system, but that are especially present for behavioral health needs like substance use, and are exacerbated by other challenges related to stigma, lack of employment, and fragmented or nonexistent care coordination. This reality reflects structural, policy, and legal misalignments common to the entire U.S.

article thumbnail

Five Public Health Needs for Digital Health Technology

The Digital Health Corner

Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies, ubiquity of mobile devices, proliferation of technology incubators, attention by government health and regulatory agencies and involvement of large companies heretofore not focused on healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Senate Committeeā€™s PREVENT Pandemics Act Draft Released: What to Know

Healthcare Law Today

It also requires that the Secretary report to Congress on the state of the SNS, and to issue guidance and hold annual meetings with public health officials and stakeholders on how states, territories, and Tribes can access the SNS. Modernizes public health data through biosurveillance and infectious disease data collection.

article thumbnail

Expanded Medicare Telehealth Coverage for Opioid Use Disorder Treatment Services Furnished by Opioid Treatment Programs

Healthcare Law Today

Prior to the federal COVID-19 Public Health Emergency (PHE), to initiate treatment with buprenorphine at an OTP, a practitioner needed to perform a complete in-person physical evaluation. The covered benefit includes MAT for patients with OUD, a leading treatment modality that combines prescribing FDA-approved medication (e.g.,

article thumbnail

The Wait is Over. Or Is It? DEAā€™s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

Should the final rules limit the issuance of prescriptions of controlled medications to the FDA-approved indications contained in the FDA-approved labeling for those medications? DEA has specifically requested feedback on whether it should limit telemedicine prescribing to only the drugā€™s FDA-approved indications. 21 U.S.C. Ā§

article thumbnail

Medical Device Cybersecurity Provisions Included in Omnibus Appropriations Bill

HIPAA Journal

Funding for the Centers for Medicare and Medicaid Services will increase by $100 million, the National Institutes of Health will receive an additional $2.5 This will help to ensure that telehealth and hospital-at-home programs can continue to provide convenient and accessible medical treatment for patients.

FDA 114
article thumbnail

Biden-?Harris Admin Awards $1.5B to Address Overdose Epidemic

HIT Consultant

Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded nearly $1.5 – Releasing New Guidance to Support and Facilitate Greater Access to FDA-approved naloxone products. What You Should Know: – The U.S